1995
DOI: 10.1002/mpo.2950240204
|View full text |Cite
|
Sign up to set email alerts
|

In situ breast carcinoma after treatment during adolescence for thyroid cancer with radioiodine

Abstract: We reviewed the courses of patients treated during childhood or adolescence for thyroid cancer to estimate the frequency of, and to identify possible risk factors for, the occurrence of second malignant tumors in this population. We identified all patients treated for thyroid cancer in a cohort of 1,406 pediatric cancer patients who were diagnosed prior to 20 years of age during the period January 1, 1960 through December 31, 1988 and who were treated at Roswell Park Cancer Institute. Twelve patients were trea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

1999
1999
2005
2005

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 41 publications
(15 reference statements)
0
4
0
Order By: Relevance
“…However, recent reports on outcome of children with thyroid carcinoma indicate that subsequent breast carcinoma may occur in this population as well; after at least 10 years of follow‐up, 5–7% developed treatment‐related lethal complications or second neoplasms, such as breast carcinoma 7. Another study of adolescent females with thyroid carcinoma corroborated these results; Green et al8 suggested that there may be an association between thyroid carcinoma and breast carcinoma that can be shown only in large population‐based studies.…”
Section: Discussionmentioning
confidence: 79%
“…However, recent reports on outcome of children with thyroid carcinoma indicate that subsequent breast carcinoma may occur in this population as well; after at least 10 years of follow‐up, 5–7% developed treatment‐related lethal complications or second neoplasms, such as breast carcinoma 7. Another study of adolescent females with thyroid carcinoma corroborated these results; Green et al8 suggested that there may be an association between thyroid carcinoma and breast carcinoma that can be shown only in large population‐based studies.…”
Section: Discussionmentioning
confidence: 79%
“…Results from the literature highlight that the percentage of permanent post‐operative complications after radical surgery is not likely to be changed 4–16. When considering the initial treatment and subsequent care of a child with PTC, one should take into account the possible impact of the morbidity of chronic therapy and follow‐up of endocrine disabilities (hypoparathyroidism and later on calcitonin deprivation); furthermore, consideration should be given to the possible iatrogenic effects of RAI therapy 18,19, and the generally indolent course of the disease considered along with this latter characteristic being independent of both the extent of disease at onset and the surgical approach undertaken. By applying a conservative surgical approach, the percentage of post‐operative complications can be reduced considerably without a deleterious influence on survival.…”
Section: Discussionmentioning
confidence: 99%
“…After total thyroidectomy, permanent hypoparathyroidism and recurrent laryngeal nerve paralysis often occurred (Table I), while after neck dissection, spinal accessory nerve paralysis was the major complication 17. In addition, iatrogenic effects of RAI therapy were reported 18,19.…”
Section: Introductionmentioning
confidence: 99%
“…11,12 In addition, an increase in the risk of breast carcinoma after thyroid carcinoma also has been reported and attributed to the carcinogenicity of RAI used to treat the thyroid carcinoma by the majority of but not all investigators. 2,[13][14][15] Apropos of the 50th anniversary of the Connecticut Tumor Registry, the NCI performed an extensive study of multiple primary cancers utilizing data from the Connecticut Tumor Registry and the Danish Cancer Registry. In an analysis of the Danish data, a study of secondary cancers in women after breast carcinoma did not show an increase in thyroid carcinoma risk (RR ϭ 1.1).…”
mentioning
confidence: 99%